Central to understanding ROP is the interplay between the vascular endothelial growth factor (VEGF) and insulin-like growth factor I (IGF-I) in terms of abnormal retinal blood vessel growth, due to the hyperoxic environments and hypoxia-induced neovascularization experienced by premature infants [1]. The gene discussed is IGF1; the disease is retinopathy of prematurity.